white coat financial partners

Revenue Due Diligence for Healthcare Practice Acquisitions: What to Verify Before You Buy

Revenue Due Diligence for Healthcare Practice Acquisitions: What to Verify Before You Buy

July 7, 2026

As healthcare M&A volume stabilizes in mid-2026, the gold standard for a successful acquisition is no longer just “growth,” but rather the rigorous verification of revenue sustainability. With the CMS 2026 Physician Fee Schedule shifting economics toward independent office-based settings, buyers must look beyond top-line numbers to ensure long-term stability.

The Key Takeaway: Precision Over Projections

The most critical step in revenue due diligence is verifying the payer mix and patient volume trends from both sides of the table. Buyers need to confirm whether a practice’s income is durable, while sellers need to present clean, defensible revenue data without compromising sensitive business information. With the CMS 2026 Physician Fee Schedule continuing to reshape outpatient economics, documented and compliant revenue remains the gold standard for a smooth transition.

Step 4: Conduct Due Diligence for Buyers and Sellers

In Stuart’s 10-step acquisition guide, Step 4: Conduct Due Diligence is where deal confidence is built or lost. For buyers, this means testing collections performance, payer concentration, coding consistency, and whether reported growth is actually converting into cash. For sellers, it means preparing organized reports, normalizing anomalies, and sharing information in phases to protect confidentiality around staff compensation, referral sources, and contract details until the process is appropriately controlled.

Verifying the Integrity of Accounts Receivable

When acquiring or selling a practice, the health of the Accounts Receivable (AR) portfolio often dictates the initial post-close success. According to the American Hospital Association (AHA), weak revenue cycle visibility can create integration risk and unexpected liquidity pressure. That is why buyers should dig deeper than an aging summary and sellers should be ready to explain timing, payer behavior, and any temporary disruptions.

A doctor and business professional shake hands finalizing a medical practice sale

Strategic Advantage with AR-Backed Working Capital

A common friction point in Step 4 is seller hesitation around data sharing. That concern is reasonable: detailed billing files, payer contracts, physician productivity, and referral patterns are highly confidential. Still, buyers should insist on disciplined review tasks such as checking for hidden denial rates, validating net collection trends, comparing deposit timing to reported production, and identifying old AR that may be unlikely to convert. Resources from the Institute for Healthcare Improvement (IHI) and Premier Inc. continue to reinforce the operational value of transparent performance measurement and revenue cycle discipline.

AR-Backed Working Capital can serve as the practical bridge between caution and execution. This non-notification lending model allows the practice owner to remain in full control of billing and collections while accessing capital against the aggregate sum of monies due. White Coat Financial Partners does not take possession of receivables or contact patients, and repayment is structured to match real cash flow rather than compounding factor fees or open-ended discount rates. For both buyers managing integration risk and sellers protecting transaction stability, it provides scalable liquidity for M&A integrations without relying solely on personal credit scores.

Collage of medical professionals reviewing efficiency and revenue growth metrics

At White Coat Financial Partners, we provide the unmatched expertise needed to turn complex revenue cycles into strategic assets. Whether you are navigating a multi-location acquisition or optimizing a solo practice, our AR-Backed Working Capital solutions offer the financial clarity, certainty, and strategic advantage required for excellence.

Contact White Coat Financial Partners today at 910-688-5077 or visit thewhitecoatadvantage.com to secure your strategic advantage.


About the Author

Stuart D. Anderson is the founder and President of White Coat Financial Partners, a Fayetteville, NC-based firm providing specialized financial and advisory services for healthcare professionals and organizations. With deep expertise in AR-backed working capital, M&A brokerage, and Lean Six Sigma process optimization, Stuart helps medical practices unlock capital, streamline operations, and achieve long-term financial stability. Connect with Stuart on LinkedIn.


Posted

in

by

Tags:

White Coat Financial Partners

Copyright  © White Coat Financial Partners